tiprankstipranks
Aptose Biosciences (TSE:APS)
TSX:APS

Aptose Biosciences (APS) Financial Statements

118 Followers

Aptose Biosciences Financial Overview

Aptose Biosciences's market cap is currently ―. The company's EPS TTM is C$-8.447; its P/E ratio is -0.12; Aptose Biosciences is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is C$-0.78. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -9.64M$ -11.96M$ -11.45M$ -14.13M$ -13.68M
EBITDA$ -9.53M$ -11.85M$ -11.45M$ -14.02M$ -13.54M
Net Income Common Stockholders$ -9.64M$ -11.96M$ -11.45M$ -14.13M$ -13.68M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 9.33M$ 9.25M$ 17.72M$ 23.31M$ 35.72M
Total Assets$ 12.80M$ 12.99M$ 20.88M$ 26.57M$ 39.33M
Total Debt$ 919.00K$ 1.01M$ 1.11M$ 1.20M$ 1.22M
Net Debt$ -8.41M$ -8.24M$ -16.61M$ -22.10M$ -34.50M
Total Liabilities$ 12.66M$ 15.89M$ 13.10M$ 12.79M$ 13.34M
Stockholders Equity$ 137.00K$ -2.90M$ 7.78M$ 13.79M$ 25.99M
Cash Flow-
Free Cash Flow$ -11.76M$ -9.26M-$ -13.52M$ -11.30M
Operating Cash Flow$ -11.76M$ -9.26M-$ -13.49M$ -11.30M
Investing Cash Flow$ -1.99M$ 1.94M-$ -1.97M$ -2.96M
Financing Cash Flow$ 11.85M$ 854.00K-$ 1.10M$ 50.00K
Currency in USD

Aptose Biosciences Earnings and Revenue History

Aptose Biosciences Debt to Assets

Aptose Biosciences Cash Flow

Aptose Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis